These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 21252842

  • 1. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan 24; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract] [Full Text] [Related]

  • 2. OnabotulinumtoxinA for treatment of chronic migraine: the unblinding problem.
    Solomon S.
    Headache; 2013 May 24; 53(5):824-6. PubMed ID: 23465058
    [No Abstract] [Full Text] [Related]

  • 3. OnabotulinumtoxinA for the treatment of chronic migraine not quite there. .
    Torgovnick J.
    Cephalalgia; 2011 Feb 24; 31(3):377; author reply 378-9. PubMed ID: 21098110
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
    Laskin DM.
    J Oral Maxillofac Surg; 2012 May 24; 70(5):1240-2. PubMed ID: 22538023
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL, Kuriyama A, Hayashino Y.
    JAMA; 2012 Apr 25; 307(16):1736-45. PubMed ID: 22535858
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
    O'Leary M, Dierich M.
    Urol Nurs; 2010 Apr 25; 30(4):228-34. PubMed ID: 20949807
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S, Arayawichanont A, Poungvarin N, Nidhinandana S, Boonkongchuen P, Towanabut S, Sithinamsuwan P, Kongsaengdao S.
    Headache; 2011 Jan 25; 51(1):52-63. PubMed ID: 21083558
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar 25; 20(114):68. PubMed ID: 21648226
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.
    Can J Neurol Sci; 2010 Sep 25; 37(5):588-94. PubMed ID: 21059503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul 25; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased Pulmonary Function During Botulinum Toxin A Therapy for Chronic Migraines in a 17-Year-Old Female.
    Oliver JD, Boesch RP, Mack KJ.
    Headache; 2018 Sep 25; 58(8):1259-1261. PubMed ID: 30033516
    [No Abstract] [Full Text] [Related]

  • 18. Can Botulinum Toxin Help Prevent Migraine in Adults?: A Cochrane Review Summary With Commentary.
    Puljak L.
    Am J Phys Med Rehabil; 2019 Mar 25; 98(3):245-246. PubMed ID: 30640292
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.